Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Bioequivalence Data: Statistical Interpretation
Regression Toward the Mean
Measurement of Bioavailability: Pharmacodynamic Methods
Testing a Claim about Standard Deviation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Yan Luo1,2, Hiroshi Kawakami3, Satoshi Funada4
1Department of Next-Generation Organ Transplantation, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
No abstract available in PubMed .
06:31Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
13:54A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
Published on: August 18, 2023